Marshall, Gerstein & Borun LLP Sponsors Pharmaceutical Trademarks Group 2014 Autumn Conference
Marshall, Gerstein & Borun LLP is pleased to sponsor the Pharmaceutical Trademarks Group (PTMG) 2014 Autumn Conference. PTMG's 89th Conference will be held October 8-10, 2014 at the Drake Hotel in Chicago and will host a distinguished group of conference presenters. The conference program, entitled "The Multi-Faceted Personality of a Pharmaceutical Trade Mark," will include a wide range of subjects relevant to the industry presented by academics, practice experts, and corporate executives. Marshall, Gerstein & Borun partners Gregory J. Chinlund, and Richard M. LaBarge will attend the conference. For more information and to view the conference agenda, click here.
Marshall, Gerstein & Borun protects and defends the intellectual property rights in billion-dollar pharmaceutical and biologic products, including EPO and the active ingredient in Cialis®. It helps clients establish a portfolio of trademark rights for pharmaceutical brands around the world, and have helped to patent more than a dozen different US-approved drugs and numerous clinical trial candidates.
The Trademark Practice Group of Marshall, Gerstein & Borun is comprised of professionals with extensive experience in all aspects of trademark selection, registration, enforcement, and litigation. The firm works closely with its clients through every phase of the branding process, and manages global trademark portfolios and enforcement programs for its clients. Marshall, Gerstein & Borun’s veteran trademark attorneys litigate trademark infringement and dilution cases, defend clients against allegations of infringement, and advise on the limits of IP rights, enabling clients to make informed decisions about how best to establish and defend proprietary rights in all media, including social media.
World Trademark Review, WTR 1000, 2011-2014 rated Marshall, Gerstein & Borun among the top US firms for trademark practice.